#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA3997697	Functional	Growth inhibition of mouse 4T1.2 cells up to 20000 nM after 48 hrs by MTT assay	Mus musculus	1	ALA3994676	cell-based format	Scientific Literature
2.	ALA3997698	Functional	Growth inhibition of mouse 4T1.2 cells up to 20000 nM encapsulated within cucurbit[8]uril after 48 hrs by MTT assay	Mus musculus	1	ALA3994676	cell-based format	Scientific Literature
3.	ALA3997702	Functional	Antitumor activity against mouse 4T1.2 cells implanted in Balb/c mouse assessed as tumor growth inhibition at 2 mg/kg, iv administered twice weekly for 2 weeks	Mus musculus	1	ALA3994676	organism-based format	Scientific Literature
4.	ALA3997703	Functional	Antitumor activity against mouse 4T1.2 cells implanted in Balb/c mouse assessed as tumor growth inhibition at 3 mg/kg, iv encapsulated within cucurbit[8]uril administered twice weekly for 2 weeks	Mus musculus	1	ALA3994676	organism-based format	Scientific Literature
5.	ALA3997704	Functional	Antitumor activity against mouse 4T1.2 cells implanted in Balb/c mouse assessed as mouse survival time at 3 mg/kg, iv encapsulated within cucurbit[8]uril administered twice weekly for 2 weeks measured up to 33 days	Mus musculus	1	ALA3994676	organism-based format	Scientific Literature
6.	ALA3997705	Functional	Antitumor activity against mouse 4T1.2 cells implanted in Balb/c mouse assessed as mouse survival rate at 2 mg/kg, iv administered twice weekly for 2 weeks measured up to 33 days (rvb = 30%)	Mus musculus	1	ALA3994676	organism-based format	Scientific Literature
7.	ALA4421211	Functional	Antitumor activity against mouse 4T1.2 cells implanted in BALB/c mouse assessed as median disease latency time at 5 to 50 mg/kg/day for 10 days and measured up to 60 days after tumor inoculation	Mus musculus	1	ALA4420080	organism-based format	Patent Bioactivity Data
8.	ALA4421212	Functional	Antitumor activity against mouse 4T1.2 cells implanted in BALB/c mouse assessed as median disease latency time at 25 mg/kg/day for 10 days (Rvb =33 days)	Mus musculus	2	ALA4420080	organism-based format	Patent Bioactivity Data
9.	ALA4421297	Functional	Antitumor activity against mouse 4T1.2 cells implanted in BALB/c mouse assessed as median disease latency time at 50 mg/kg/day for 10 days (Rvb =40 days)	Mus musculus	1	ALA4420080	organism-based format	Patent Bioactivity Data
10.	ALA4421298	Functional	Antitumor activity against mouse 4T1.2 cells implanted in BALB/c mouse assessed as effect on tumor size at 25 mg/kg/day for 10 days	Mus musculus	1	ALA4420080	organism-based format	Patent Bioactivity Data
11.	ALA4421299	Functional	Antitumor activity against mouse 4T1.2 cells implanted in BALB/c mouse assessed as reduction in mean number of lung metastases at 25 mg/kg/day for 10 days measured at day 28 after tumor inoculation relative to control	Mus musculus	1	ALA4420080	organism-based format	Patent Bioactivity Data
12.	ALA4421300	Functional	Antitumor activity against mouse 4T1.2 cells implanted in BALB/c mouse undergoing sham surgery without excising tumor on day 12 assessed as effect on mouse survival at 25 mg/kg/day for 10 days	Mus musculus	1	ALA4420080	organism-based format	Patent Bioactivity Data
13.	ALA4421301	Functional	Inhibition of tumor induced vascular response in mouse 4T1.2 cells implanted BALB/c mouse assessed as reduction in blood vessel coverage at 25 mg/kg/day for 10 days by bright field microscopy	Mus musculus	1	ALA4420080	organism-based format	Patent Bioactivity Data
14.	ALA4421302	Functional	Inhibition of tumor induced vascular response in mouse 4T1.2 cells implanted BALB/c mouse assessed as reduction in number of endothelial cells in tumor region at 25 mg/kg/day for 10 days by ERG/EMCN-detection based immunofluorescent staining relative to control	Mus musculus	1	ALA4420080	organism-based format	Patent Bioactivity Data
15.	ALA4421303	Functional	Inhibition of tumor induced vascular response in mouse 4T1.2 cells implanted BALB/c mouse assessed as reduction in volume of the blood vessels in tumor region at 25 mg/kg/day for 10 days by ERG/EMCN-detection based immunofluorescent staining relative to control	Mus musculus	1	ALA4420080	organism-based format	Patent Bioactivity Data
16.	ALA4421304	Functional	Inhibition of tumor induced lymphangiogenesis response in mouse 4T1.2 cells implanted BALB/c mouse assessed as reduction in tumor associated lymphatic vessels at 25 mg/kg/day for 10 days by PROX1/podoplanin detection based immunofluorescent staining relative to control	Mus musculus	1	ALA4420080	organism-based format	Patent Bioactivity Data
17.	ALA4421305	Functional	Inhibition of tumor induced lymphangiogenesis response in mouse 4T1.2 cells implanted BALB/c mouse assessed as reduction in number of lymphatic endothelial cells at 25 mg/kg/day for 10 days by PROX1/podoplanin detection based immunofluorescent staining relative to control	Mus musculus	1	ALA4420080	organism-based format	Patent Bioactivity Data